Role of Protein C Inhibitor and Tissue Factor in Fertilization

ABSTRACT

Semen coagulation is achieved by a series of biochemical processes designed to protect and guide the sperm during its migration through the female genital tract so that spermatozoa reach the ovum successfully. Thus, semen coagulation promotes fertilization. The mechanism of semen coagulation is similar in principle to blood coagulation and fibrinolysis because it requires the catalytic activity of proteases to convert a soluble substrate to an insoluble gel, and then dissolve the gel over a longer period of time. In fact, there are traces of most blood coagulation factors and fibrinolytic factors in semen; the roles of these factors in semen coagulation are still to be determined. This review focuses on two such proteins that have remarkably high levels in semen: protein C inhibitor and tissue factor. Protein C inhibitor is a serine protease inhibitor that modulates the activity of several blood-clotting factors and activated protein C. Tissue factor (thromboplastin) is a membrane protein crucial for the initiation of the extrinsic cascade of blood coagulation. The emerging roles of these two proteins in semen coagulation and in fertilization processes are summarized.

KEYWORDS

Protein C inhibitor - tissue factor - fertilization - semen coagulation - kallikreins

REFERENCES

• 1 De Jonge C J. An update on human fertilization.  Semin Reprod Endocrinol. 1998;  16 209-217
• 2 Luconi M, Baldi E. How do sperm swim? Molecular mechanisms underlying sperm motility.  Cell Mol Biol. 2003;  49 357-369
• 3 De Jonge C. Biological basis for human capacitation.  Hum Reprod Update. 2005;  11 205-214
• 4 Aitken R J. The cell biology of fertilization.  Fate of the male germ cell. Advances in Experimental Medicine and Biology. 1997;  424 291-299
• 5 Jonsson M, Linse S, Frohm B, Lundwall A, Malm J. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen.  Biochem J. 2005;  387 447-453
• 6 Fung K YC, Glode L M, Green S, Duncan M W. A comprehensive characterization of the peptide and protein constituents of human seminal fluid.  Prostate. 2004;  61 171-181
• 7 Lwaleed B A, Greenfield R, Stewart A, Birch B, Cooper A J. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system.  Thromb Haemost. 2004;  92 752-766
• 8 España F, Gilabert J, Estelles A et al.. Functionally active protein C inhibitor plasminogen-activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.  Thromb Res. 1991;  64 309-320
• 9 Fernández J A, Heeb M J, Radtke K P, Griffin J H. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor.  Biol Reprod. 1997;  56 757-763
• 10 Suzuki K. Protein C inhibitor (PAI-3): structure and multi-function.  Fibrinol Proteol. 2000;  14 133-145
• 11 Heeb M J, España F, Geiger M et al.. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.  J Biol Chem. 1987;  262 15813-15816
• 12 Meijers J CM, Chung D W. Organization of the gene coding for human protein C inhibitor (plasminogen-activator inhibitor-3): assignment of the gene to chromosome-14.  J Biol Chem. 1991;  266 15028-15034
• 13 Laurell M, Christensson A, Abrahamsson P A, Stenflo J, Lilja H. Protein C inhibitor in human body fluids: Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.  J Clin Invest. 1992;  89 1094-1101
• 14 Anway M D, Show M D, Zirkin B R. Protein C inhibitor expression by adult rat sertoli cells: Effects of testosterone withdrawal and replacement.  J Androl. 2005;  26 578-585
• 15 Wakita T, Hayashi T, Yuasa H et al.. Molecular cloning, tissue distribution and androgen regulation of rat protein C inhibitor.  FEBS Lett. 1998;  429 263-268
• 16 Elisen M GLM, van Kooij R J, Nolte M A et al.. Protein C inhibitor may modulate human sperm-oocyte interactions.  Biol Reprod. 1998;  58 670-677
• 17 Kise H, Nishioka J, Kawamura J, Suzuki K. Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor.  Eur J Biochem. 1996;  238 88-96
• 18 España F, Fink E, Sanchez-Cuenca J et al.. Complexes of tissue kallikrein with protein C inhibitor in human semen and urine.  Eur J Biochem. 1995;  234 641-649
• 19 Heeb M J, España F. Alpha₂-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein (hK2).  Blood Cells Mol Dis. 1998;  24 411-418
• 20 Lovgren J, Airas K, Lilja H. Enzymatic action of human glandular kallikrein 2 (hK2): Substrate specificity and regulation by Zn²⁺ and extracellular protease inhibitors.  Eur J Biochem. 1999;  262 781-789
• 21 Uhrin P, Dewerchin M, Hilpert M et al.. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility.  J Clin Invest. 2000;  106 1531-1539
• 22 Odet F, Guyot R, Leduque P, Magueresse-Battistoni B. Evidence for similar expression of protein C inhibitor and the urokinase-type plasminogen activator system during mouse testis development.  Endocrinology. 2004;  145 1481-1489
• 23 España F, Estelles A, Hendl S M et al.. Evidence for the physiological regulation of urokinase and tissue-type plasminogen activators by the serpin, protein C inhibitor, in semen, urine and blood.  Thromb Haemost. 1993;  70 989-994
• 24 Lison D, Tas S, Gennart J P et al.. Plasminogen activator activity and fertilizing ability of human spermatozoa.  Int J Androl. 1993;  16 201-206
• 25 Christensson A, Bjartell A, Lilja H. The significance of serpins in the regulation of proteases in the male genital tract.  Chem Biol Serpins Advances in Experimental Medicine and Biology. 1997;  425 163-176
• 26 Zheng X L, Zechmeister-Machhart M, Uhrin P et al.. Effect of protein C inhibitor (PCI) on in vitro fertilization.  Immunopharmacology. 1996;  33 140-142
• 27 Zheng X L, Geiger M, Ecke S et al.. Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa.  Am J Physiol. 1994;  267 C466-C472
• 28 Tulsiani D RP, Abou-Haila A, Loeser C R, Pereira B MJ. The biological and functional significance of the sperm acrosome and acrosomal enzymes in mammalian fertilization.  Exp Cell Res. 1998;  240 151-164
• 29 España F, Sanchez-Cuenca J, Fernández P J et al.. Inhibition of human sperm-zona-free hamster oocyte binding and penetration by protein C inhibitor.  Andrologia. 1999;  31 217-223
• 30 España F, Estelles A, Griffin J H, Aznar J. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.  Thromb Haemost. 1991;  65 46-51
• 31 Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen.  Eur J Biochem. 1994;  220 45-53
• 32 España F, Sanchez-Cuenca J, Estelles A et al.. Quantitative immunoassay for complexes of prostate-specific antigen with alpha₂-macroglobulin.  Clin Chem. 1996;  42 545-550
• 33 Riegman P HJ, Vlietstra R J, Klaassen P et al.. The prostate specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome-19.  FEBS Lett. 1989;  247 123-126
• 34 Lilja H. Structure, Function, and regulation of the enzyme activity of prostate-specific antigen.  World J Urol. 1993;  11 188-191
• 35 Malm J, Hellman J, Hogg P, Lilja H. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn²⁺, a tight binding inhibitor.  Prostate. 2000;  45 132-139
• 36 Christensson A, Laurell C B, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.  Eur J Biochem. 1990;  194 755-763
• 37 Villoutreix B O, Lilja H, Pettersson K, Lovgren T, Teleman O. Structural investigation of the alpha₁-antichymotrypsin: prostate-specific antigen complex by comparative model building.  Protein Sci. 1996;  5 836-851
• 38 Seregni E, Botti C, Ballabio G, Bombardieri E. Biochemical characteristics and recent biological knowledge on prostate-specific antigen.  Tumori. 1996;  82 72-77
• 39 Malm J, Hellman J, Magnusson H, Laurell C B, Lilja H. Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II.  Eur J Biochem. 1996;  238 48-53
• 40 Takayama T K, Fujikawa K, Davie E W. Characterization of the precursor of prostate-specific antigen: activation by trypsin and by human glandular kallikrein.  J Biol Chem. 1997;  272 21582-21588
• 41 Frenette G, Deperthes D, Tremblay R R, Lazure C, Dube J Y. Purification of enzymatically active kallikrein hK2 from human seminal plasma.  Biochim Biophys Acta. 1997;  1334 109-115
• 42 Ecke S, Geiger M, Resch I et al.. Inhibition of tissue kallikrein by protein C inhibitor: evidence for identity of protein C inhibitor with the kallikrein binding protein.  J Biol Chem. 1992;  267 7048-7052
• 43 Geiger M, Zechmeister-Machhart M, Uhrin P et al.. Protein C inhibitor (PCI).  Immunopharmacology. 1996;  32 53-56
• 44 Rao L VM, Pendurthi U R. Tissue factor-factor VIIa signaling.  Arterioscler Thromb Vasc Biol. 2005;  25 47-56
• 45 Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development.  Arterioscler Thromb Vasc Biol. 2004;  24 1015-1022
• 46 Chu A J. Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.  Front Biosci. 2006;  11 256-271
• 47 Lwaleed B A, Greenfield R S, Birch B R, Cooper A J. Does human semen contain a functional haemostatic system? A possible role for tissue factor pathway inhibitor in fertility through semen liquefaction.  Thromb Haemost. 2005;  93 847-852
• 48 Ohta S, Wada H, Gabazza E C, Nobori T, Fuse H. Evaluation of tissue factor antigen level in human seminal plasma.  Urol Res. 2002;  30 317-320
• 49 Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer.  Arterioscler Thromb Vasc Biol. 2005;  25 1545-1550
• 50 Babiker A A. Prostasome Modulation of Blood Cascade System and Phosphoprotein Reactions with Focus on Prostate Cancer [dissertation 1-65]. Uppsala, Sweden, Uppsala University 2005
• 51 Fan Z Q, Larson P J, Bognacki J et al.. Tissue factor regulates plasminogen binding and activation.  Blood. 1998;  91 1987-1998
• 52 Gonzalez-Gronow M, Gawdi G, Pizzo S V. Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells.  Blood. 2002;  99 4562-4567
• 53 Riewald M, Huang H Y, Ott I et al.. Tissue factor-mediated cell adhesion and signaling is dependent on actin binding protein 280 (filamin-1).  Blood. 1998;  92 474 (Abst)
• 54 Fischer E G, Riewald M, Huang H Y et al.. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.  J Clin Invest. 1999;  104 1213-1221
• 55 Kobayashi T, Matsuda Y, Park J Y et al.. Trypsin-like arginine amidases including plasminogen and plasmin in human seminal plasma by affinity adsorption and elution.  Arch Androl. 1992;  28 165-170
• 56 Smokovitis A, Kokolis N, Taitzoglou I, Rekkas C. Plasminogen activator: the identification of an additional proteinase at the outer acrosomal membrane of human and boar spermatozoa.  Int J Fertil. 1992;  37 308-314
• 57 Llanos M N, Lui C W, Meizel S. Studies of phospholipase-A₂ related to the hamster sperm acrosome reaction.  J Exp Zool. 1982;  221 107-117
• 58 Taitzoglou L A, Chapman D A, Zervos I A, Killian G J. Effect of plasmin on movement characteristics of ejaculated bull spermatozoa.  Theriogenology. 2004;  62 553-561
• 59 Ronquist G, Nilsson B O. The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth.  Prostate Cancer Prostatic Dis. 2004;  7 21-31
• 60 Arienti G, Carlini E, Saccardi C, Palmerini C A. Role of human prostasomes in the activation of spermatozoa.  J Cell Mol Med. 2004;  8 77-84
• 61 Palmerini C A, Saccardi C, Carlini E, Fabiani R, Arienti G. Fusion of prostasomes to human spermatozoa stimulates the acrosome reaction.  Fertil Steril. 2003;  80 1181-1184
• 62 Kravets F G, Lee J, Singh B et al.. Prostasomes: current concepts.  Prostate. 2000;  43 169-174